Itamar Medical Ltd
ITMMF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $194,000.00 |
| Earnings per Share | $- |
| Beta | - |
| Outstanding Shares | - |
Return
| Return on Equity | -25.34% |
|---|---|
| Return on Assets | -18.30% |
| Return on Invested Capital | -21.58% |
Valuation & Multiples
| P/E Ratio | - |
|---|---|
| PEG | - |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0 |
| Enterprise Value to EBIT | -0.01 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 55.92 |
| Debt to Equity | 0.15 |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Itamar Medical Ltd.
CEO: Gilad Glick
Itamar Medical Ltd. engages in the research, development, marketing, selling, and leasing of non-invasive medical devices based on peripheral arterial tone signals. It develops and markets two products, namely, WatchPAT and EndoPAT. The ...